Estrov Z - Search Results

1

Studies of minimal residual disease in acute lymphocytic leukemia.

Stock W, Estrov Z. Stock W, et al. Among authors: estrov z. Hematol Oncol Clin North Am. 2000 Dec;14(6):1289-305, viii-ix. doi: 10.1016/s0889-8588(05)70187-8. Hematol Oncol Clin North Am. 2000. PMID: 11147224 Review.

2

Juvenile chronic myelogenous leukemia.

Freedman MH, Estrov Z, Chan HS. Freedman MH, et al. Among authors: estrov z. Am J Pediatr Hematol Oncol. 1988 Fall;10(3):261-7. doi: 10.1097/00043426-198823000-00016. Am J Pediatr Hematol Oncol. 1988. PMID: 3052147 Review.

3

Residual disease in acute lymphoblastic leukemia of childhood: methods of detection and clinical relevance.

Faderl S, Estrov Z. Faderl S, et al. Among authors: estrov z. Cytokines Cell Mol Ther. 1998 Jun;4(2):73-85. Cytokines Cell Mol Ther. 1998. PMID: 9681246 Review.

4

Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making?

Faderl S, Talpaz M, Kantarjian HM, Estrov Z. Faderl S, et al. Among authors: estrov z. Blood. 1999 May 1;93(9):2755-9. Blood. 1999. PMID: 10216068 Free article. Review. No abstract available.

5

The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.

Faderl S, Kantarjian HM, Manshouri T, Chan CY, Pierce S, Hays KJ, Cortes J, Thomas D, Estrov Z, Albitar M. Faderl S, et al. Among authors: estrov z. Clin Cancer Res. 1999 Jul;5(7):1855-61. Clin Cancer Res. 1999. PMID: 10430092

6

Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia.

Faderl S, Thall PF, Kantarjian HM, Talpaz M, Harris D, Van Q, Beran M, Kornblau SM, Pierce S, Estrov Z. Faderl S, et al. Among authors: estrov z. Clin Cancer Res. 1999 Dec;5(12):4041-7. Clin Cancer Res. 1999. PMID: 10632337

7

Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.

Faderl S, Kantarjian HM, Thomas DA, Cortes J, Giles F, Pierce S, Albitar M, Estrov Z. Faderl S, et al. Among authors: estrov z. Leuk Lymphoma. 2000 Jan;36(3-4):263-73. doi: 10.3109/10428190009148847. Leuk Lymphoma. 2000. PMID: 10674898

8

Clinical significance of minimal residual disease in leukemia.

Faderl S, Kantarjian HM, Talpaz M, Estrov Z. Faderl S, et al. Among authors: estrov z. Int J Oncol. 2000 Dec;17(6):1277-87. doi: 10.3892/ijo.17.6.1277. Int J Oncol. 2000. PMID: 11078816 Review.

9

CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia.

Ravandi F, Cortes J, Estrov Z, Thomas D, Giles FJ, Huh YO, Pierce S, O'Brien S, Faderl S, Kantarjian HM. Ravandi F, et al. Among authors: estrov z. Leuk Res. 2002 Jul;26(7):643-9. doi: 10.1016/s0145-2126(01)00188-6. Leuk Res. 2002. PMID: 12008081

10

Interleukin-7 receptor-α gene mutations are not detected in adult T-cell acute lymphoblastic leukemia.

Rozovski U, Li P, Harris D, Ohanian M, Kantarjian H, Estrov Z. Rozovski U, et al. Among authors: estrov z. Cancer Med. 2014 Jun;3(3):550-4. doi: 10.1002/cam4.194. Epub 2014 Mar 26. Cancer Med. 2014. PMID: 24678068 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

507 results

Search Page

Filters